Subsequent experiments confirmed this hypothesis; we found that METTL16 inhibits CAPN2 expression by regulating MROH8, which in turn affects the progression and metastasis of pancreatic cancer. The gene discussed is METTL16; the disease is familial pancreatic carcinoma.